Navigation Links
Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
Date:1/7/2011

as CMV, herpes simplex virus and Epstein Barr virus, polyoma viruses such as BK virus and JC virus, and pox viruses.

Over 325 people have received CMX001 to date, including over 130 patients treated under Emergency INDs.  CMX001 has been well tolerated in all studies, with a growing body of evidence of the compound's antiviral activity in humans.  CMX001 is also being developed as a medical countermeasure in the event of a smallpox outbreak.  Chimerix has received significant funding from the National Institute of Allergy and Infectious Disease to develop CMX001 for smallpox.

Chimerix's second clinical-stage antiviral compound CMX157, a potent nucleoside analogue with activity against HIV and hepatitis B, is in development for the treatment of HIV infection including those caused by multi-drug resistant viruses.  CMX157 has completed Phase 1 clinical studies demonstrating that the compound is well tolerated and that the active antiviral, TFV-PP, was measurable in peripheral blood mononuclear cells (PBMCs) after a single dose and remained detectable for six days, suggesting the possibility of a convenient, once-weekly dosing regimen. CMX157's promising safety profile and efficient conversion to the active drug in PBMCs, coupled with the potent in vitro antiviral activity across diverse drug-resistant strains of HIV, indicate that this compound may directly address several limitations of current HIV therapies.

Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, malaria and other global public health needs.  For additional information on Chimerix, please visit http://www.chimerix.com.

(1) Code of Federal Regulations, Title 21, Revised April 2010


'/>"/>
SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
2. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
3. Chimerix to Present at Two Upcoming Investor Conferences
4. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
5. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
6. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
7. Chimerix to Present at 9th Annual BIO Investor Forum
8. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
9. Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
10. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
11. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 /CNW/ - The Canadian Pharmacists Association (CPhA) ... strategy to ensure that all Canadians have the opportunity ... (human papillomavirus) through immunization. The lack of access to ... Canada is needlessly putting the health of ... as HPV, continue to pose a significant threat to ...
(Date:7/6/2015)... July 6, 2015   BioClinica®, Inc ., ... today announced that it has acquired a leading ... , Inc. (Medici).  The acquisition includes affiliates ... Medici also provides a lost-to-follow-up patient locate service ...  Together with Medici, BioClinica will offer ...
(Date:7/6/2015)... 29, 2015 Research and ... "Urinary Slings Market in the US 2015-2019" ... the Urinary Slings market in the US to grow ... 2014-2019. This report covers the present scenario and ... the US for the period 2015-2019. To calculate the ...
Breaking Medicine Technology:CPhA Calls for HPV Strategy for Young Men to Save Lives 2BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2
... May 9, 2012 /PRNewswire-iReach/ -- Global Information ... in rapidly expanding Protein Therapy market: ... Protein-based therapies have become one of the most ... ranging from cancer to metabolic disorders. While worldwide healthcare spending ...
... 2012  Millstone Medical Outsourcing announced today that the ... Quality Systems.  As a seasoned quality specialist with ... for managing the quality systems for all of ... working closely with customers to ensure the highest ...
Cached Medicine Technology:New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015 2Millstone Medical Outsourcing Hires New Vice President Quality 2
(Date:7/6/2015)... ... July 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics ... to grow at a CAGR of over 3.2 percent in the years to come ... to be mainly spurred by an anticipated launch of a number of promising pipeline ...
(Date:7/6/2015)... Chester, NJ (PRWEB) , ... July 06, 2015 ... ... CancerHopeNetwork.org. The redesigned site allows newly-diagnosed cancer patients, caregivers and medical professionals to ... who has survived the same cancer. , “Receiving a cancer diagnosis is often ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... In a ... learn how to reduce their risk of having a fracture through the bone health ... Fractures Awareness Day. , “We are participating because our residents need this information to ...
(Date:7/6/2015)... ... 06, 2015 , ... Promero, a leading cloud hosting provider ... IP contact center solution hosted by Promero. Randstad Technologies,a leading talent and ... call center platform. , Promero will implement and manage the private cloud ...
(Date:7/5/2015)... ... 06, 2015 , ... Security Life Insurance Company of America, ... generation of PrimeStar Individual Dental Insurance. Beginning now, enhancements include the expansion of ... Charge (MAC) and usual, customary and reasonable (UCR). , Whether consumers are ...
Breaking Medicine News(10 mins):Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:National Bone Health Screening and Awareness Day 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... YORK, March 1, 2012 A nutrient found in the ... disease (CHD) in women with high cholesterol, according to a ... The study, published online in the European Journal of ... found in the dark meat of turkey and chicken, as ...
... By Ellin Holohan HealthDay Reporter , THURSDAY, March ... trans fats in your diet, especially if you are an ... risk of stroke among postmenopausal women who ate the highest ... and packaged products. The research, done at the University ...
... A team of 18 researchers at Moffitt Cancer Center ... sarcoma patients with a combination of implanted dendritic cells (immune ... than 50 percent of their trial patients with tumor-specific immune ... study was published in a recent issue of the ...
... 2012) Imaging amino acid transporters with positron ... significantly alter intended management plans for patients with ... issue of The Journal of Nuclear Medicine ... radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-L-phenylalanine (F-18-DOPA), physicians changed the intended management ...
... first audit of leukaemia treatment and survival in Northern Ireland ... shown that survival rates for the disease here are at ... For children with the disease, survival has improved dramatically ... the current level of over 80 per cent for five ...
... THURSDAY, March 1 (HealthDay News) -- Teens with chronic fatigue ... as joint and muscle pain, may benefit from an Internet-based ... Researchers in the Netherlands studied teens with the debilitating ... better or had recovered after six months of the Web-based ...
Cached Medicine News:Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 2Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 3Health News:Trans Fats May Raise Stroke Risk in Older Women 2Health News:Trans Fats May Raise Stroke Risk in Older Women 3Health News:Researchers find sarcoma tumor immune response with combination therapy 2Health News:PET tracer changes management plan for brain tumor patients 2Health News:New study reveals more people surviving leukaemia and pancreatic cancer in Northern Ireland 2Health News:New study reveals more people surviving leukaemia and pancreatic cancer in Northern Ireland 3Health News:Web-Based Therapy May Help Teens With Chronic Fatigue 2
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Leica surgical ...
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
Introducing Optronics DVMR, the first digital surgical documentation system designed for the microsurgical operating room environment. DVMR accepts images from a variety of high-resolution cameras fo...
Research Grade Microscope Camera from ImagingPlanet Research Microscopy Group, a superior imaging technology that delivers increased image resolution and precise color accuracy at an affordable pric...
Medicine Products: